{
  "study_id": "French R98 Intergroup trial",
  "study_title": "Postoperative irinotecan in resected stage II-III rectal cancer: final analysis of the French R98 Intergroup trial",
  "table_name": "Table 1",
  "table_title": "Characteristics of 357 assessable patients",
  "footnotes": [],
  "groups": [
    {
      "name": "Control arm",
      "n": 178
    },
    {
      "name": "LV5-FU2 + irinotecan arm",
      "n": 179
    },
    {
      "name": "All",
      "n": 357
    }
  ],
  "characteristics": [
    {
      "original_label": "Sex (%): male/female",
      "standardized_name": "Sex",
      "unit": "%",
      "category": "Demographics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "header",
          "raw_string": "male/female"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "header",
          "raw_string": "male/female"
        },
        {
          "group_name": "All",
          "data_type": "header",
          "raw_string": "male/female"
        }
      ]
    },
    {
      "original_label": "male",
      "standardized_name": "Sex, male",
      "unit": "%",
      "category": "Demographics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sex",
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "categorical_count_percentage",
          "percentage": 68.0,
          "raw_string": "68/32"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "categorical_count_percentage",
          "percentage": 67.0,
          "raw_string": "67/33"
        },
        {
          "group_name": "All",
          "data_type": "categorical_count_percentage",
          "percentage": 68.0,
          "raw_string": "68/32"
        }
      ]
    },
    {
      "original_label": "female",
      "standardized_name": "Sex, female",
      "unit": "%",
      "category": "Demographics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sex",
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "categorical_count_percentage",
          "percentage": 32.0,
          "raw_string": "68/32"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "categorical_count_percentage",
          "percentage": 33.0,
          "raw_string": "67/33"
        },
        {
          "group_name": "All",
          "data_type": "categorical_count_percentage",
          "percentage": 32.0,
          "raw_string": "68/32"
        }
      ]
    },
    {
      "original_label": "Median age [range]",
      "standardized_name": "Age",
      "unit": "years",
      "category": "Demographics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "numeric_median_iqr",
          "median": 64.0,
          "iqr_min": 33.0,
          "iqr_max": 82.0,
          "raw_string": "64 [33-82]",
          "notes": "The source reports a range, which is represented here as an interquartile range."
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "numeric_median_iqr",
          "median": 61.0,
          "iqr_min": 32.0,
          "iqr_max": 80.0,
          "raw_string": "61 [32-80]",
          "notes": "The source reports a range, which is represented here as an interquartile range."
        },
        {
          "group_name": "All",
          "data_type": "numeric_median_iqr",
          "median": 62.0,
          "iqr_min": 32.0,
          "iqr_max": 82.0,
          "raw_string": "62 [32-82]",
          "notes": "The source reports a range, which is represented here as an interquartile range."
        }
      ]
    },
    {
      "original_label": "ECOG performance status (%): 0/1/2",
      "standardized_name": "ECOG Performance Status",
      "unit": "%",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "header",
          "raw_string": "0/1/2"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "header",
          "raw_string": "0/1/2"
        },
        {
          "group_name": "All",
          "data_type": "header",
          "raw_string": "0/1/2"
        }
      ]
    },
    {
      "original_label": "0",
      "standardized_name": "ECOG Performance Status, 0",
      "unit": "%",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "ECOG Performance Status",
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "categorical_count_percentage",
          "percentage": 58.0,
          "raw_string": "58/28/2"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "categorical_count_percentage",
          "percentage": 65.0,
          "raw_string": "65/23/2"
        },
        {
          "group_name": "All",
          "data_type": "categorical_count_percentage",
          "percentage": 62.0,
          "raw_string": "62/26/2"
        }
      ]
    },
    {
      "original_label": "1",
      "standardized_name": "ECOG Performance Status, 1",
      "unit": "%",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "ECOG Performance Status",
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "categorical_count_percentage",
          "percentage": 28.0,
          "raw_string": "58/28/2"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "categorical_count_percentage",
          "percentage": 23.0,
          "raw_string": "65/23/2"
        },
        {
          "group_name": "All",
          "data_type": "categorical_count_percentage",
          "percentage": 26.0,
          "raw_string": "62/26/2"
        }
      ]
    },
    {
      "original_label": "2",
      "standardized_name": "ECOG Performance Status, 2",
      "unit": "%",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "ECOG Performance Status",
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "categorical_count_percentage",
          "percentage": 2.0,
          "raw_string": "58/28/2"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "categorical_count_percentage",
          "percentage": 2.0,
          "raw_string": "65/23/2"
        },
        {
          "group_name": "All",
          "data_type": "categorical_count_percentage",
          "percentage": 2.0,
          "raw_string": "62/26/2"
        }
      ]
    },
    {
      "original_label": "Site of primary tumour (%): high/low rectum",
      "standardized_name": "Primary Tumor Site",
      "unit": "%",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "header",
          "raw_string": "high/low rectum"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "header",
          "raw_string": "high/low rectum"
        },
        {
          "group_name": "All",
          "data_type": "header",
          "raw_string": "high/low rectum"
        }
      ]
    },
    {
      "original_label": "high rectum",
      "standardized_name": "Primary Tumor Site, high rectum",
      "unit": "%",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Primary Tumor Site",
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "categorical_count_percentage",
          "percentage": 47.0,
          "raw_string": "47/53"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "categorical_count_percentage",
          "percentage": 47.0,
          "raw_string": "47/53"
        },
        {
          "group_name": "All",
          "data_type": "categorical_count_percentage",
          "percentage": 47.0,
          "raw_string": "47/53"
        }
      ]
    },
    {
      "original_label": "low rectum",
      "standardized_name": "Primary Tumor Site, low rectum",
      "unit": "%",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Primary Tumor Site",
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "categorical_count_percentage",
          "percentage": 53.0,
          "raw_string": "47/53"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "categorical_count_percentage",
          "percentage": 53.0,
          "raw_string": "47/53"
        },
        {
          "group_name": "All",
          "data_type": "categorical_count_percentage",
          "percentage": 53.0,
          "raw_string": "47/53"
        }
      ]
    },
    {
      "original_label": "Number of involved nodes (%): 0/1-3/>3",
      "standardized_name": "Number of Involved Nodes",
      "unit": "%",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "header",
          "raw_string": "0/1-3/>3"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "header",
          "raw_string": "0/1-3/>3"
        },
        {
          "group_name": "All",
          "data_type": "header",
          "raw_string": "0/1-3/>3"
        }
      ]
    },
    {
      "original_label": "0",
      "standardized_name": "Number of Involved Nodes, 0",
      "unit": "%",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Number of Involved Nodes",
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "categorical_count_percentage",
          "percentage": 32.0,
          "raw_string": "32/48/20"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "categorical_count_percentage",
          "percentage": 31.0,
          "raw_string": "31/48/21"
        },
        {
          "group_name": "All",
          "data_type": "categorical_count_percentage",
          "percentage": 32.0,
          "raw_string": "32/48/20"
        }
      ]
    },
    {
      "original_label": "1-3",
      "standardized_name": "Number of Involved Nodes, 1-3",
      "unit": "%",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Number of Involved Nodes",
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "categorical_count_percentage",
          "percentage": 48.0,
          "raw_string": "32/48/20"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "categorical_count_percentage",
          "percentage": 48.0,
          "raw_string": "31/48/21"
        },
        {
          "group_name": "All",
          "data_type": "categorical_count_percentage",
          "percentage": 48.0,
          "raw_string": "32/48/20"
        }
      ]
    },
    {
      "original_label": ">3",
      "standardized_name": "Number of Involved Nodes, >3",
      "unit": "%",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Number of Involved Nodes",
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "categorical_count_percentage",
          "percentage": 20.0,
          "raw_string": "32/48/20"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "categorical_count_percentage",
          "percentage": 21.0,
          "raw_string": "31/48/21"
        },
        {
          "group_name": "All",
          "data_type": "categorical_count_percentage",
          "percentage": 20.0,
          "raw_string": "32/48/20"
        }
      ]
    },
    {
      "original_label": "Preoperative radiotherapy (%): yes/no",
      "standardized_name": "Preoperative Radiotherapy",
      "unit": "%",
      "category": "Treatment History",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "header",
          "raw_string": "yes/no"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "header",
          "raw_string": "yes/no"
        },
        {
          "group_name": "All",
          "data_type": "header",
          "raw_string": "yes/no"
        }
      ]
    },
    {
      "original_label": "yes",
      "standardized_name": "Preoperative Radiotherapy, yes",
      "unit": "%",
      "category": "Treatment History",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Preoperative Radiotherapy",
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "categorical_count_percentage",
          "percentage": 69.0,
          "raw_string": "69/31"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "categorical_count_percentage",
          "percentage": 69.0,
          "raw_string": "69/31"
        },
        {
          "group_name": "All",
          "data_type": "categorical_count_percentage",
          "percentage": 69.0,
          "raw_string": "69/31"
        }
      ]
    },
    {
      "original_label": "no",
      "standardized_name": "Preoperative Radiotherapy, no",
      "unit": "%",
      "category": "Treatment History",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Preoperative Radiotherapy",
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "categorical_count_percentage",
          "percentage": 31.0,
          "raw_string": "69/31"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "categorical_count_percentage",
          "percentage": 31.0,
          "raw_string": "69/31"
        },
        {
          "group_name": "All",
          "data_type": "categorical_count_percentage",
          "percentage": 31.0,
          "raw_string": "69/31"
        }
      ]
    },
    {
      "original_label": "Sphincter conservation (%): yes/no",
      "standardized_name": "Sphincter Conservation",
      "unit": "%",
      "category": "Surgical Details",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "header",
          "raw_string": "yes/no"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "header",
          "raw_string": "yes/no"
        },
        {
          "group_name": "All",
          "data_type": "header",
          "raw_string": "yes/no"
        }
      ]
    },
    {
      "original_label": "yes",
      "standardized_name": "Sphincter Conservation, yes",
      "unit": "%",
      "category": "Surgical Details",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sphincter Conservation",
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "categorical_count_percentage",
          "percentage": 80.0,
          "raw_string": "80/20"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "categorical_count_percentage",
          "percentage": 79.0,
          "raw_string": "79/21"
        },
        {
          "group_name": "All",
          "data_type": "categorical_count_percentage",
          "percentage": 80.0,
          "raw_string": "80/20"
        }
      ]
    },
    {
      "original_label": "no",
      "standardized_name": "Sphincter Conservation, no",
      "unit": "%",
      "category": "Surgical Details",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sphincter Conservation",
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "categorical_count_percentage",
          "percentage": 20.0,
          "raw_string": "80/20"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "categorical_count_percentage",
          "percentage": 21.0,
          "raw_string": "79/21"
        },
        {
          "group_name": "All",
          "data_type": "categorical_count_percentage",
          "percentage": 20.0,
          "raw_string": "80/20"
        }
      ]
    },
    {
      "original_label": "Time from surgery (weeks): 0-4/>4",
      "standardized_name": "Time from Surgery to Treatment",
      "unit": "%",
      "category": "Treatment History",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "header",
          "raw_string": "0-4/>4"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "header",
          "raw_string": "0-4/>4"
        },
        {
          "group_name": "All",
          "data_type": "header",
          "raw_string": "0-4/>4"
        }
      ]
    },
    {
      "original_label": "0-4",
      "standardized_name": "Time from Surgery to Treatment, 0-4 weeks",
      "unit": "%",
      "category": "Treatment History",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Time from Surgery to Treatment",
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "categorical_count_percentage",
          "percentage": 44.0,
          "raw_string": "44/56"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "categorical_count_percentage",
          "percentage": 44.0,
          "raw_string": "44/56"
        },
        {
          "group_name": "All",
          "data_type": "categorical_count_percentage",
          "percentage": 44.0,
          "raw_string": "44/56"
        }
      ]
    },
    {
      "original_label": ">4",
      "standardized_name": "Time from Surgery to Treatment, >4 weeks",
      "unit": "%",
      "category": "Treatment History",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Time from Surgery to Treatment",
      "group_data": [
        {
          "group_name": "Control arm",
          "data_type": "categorical_count_percentage",
          "percentage": 56.0,
          "raw_string": "44/56"
        },
        {
          "group_name": "LV5-FU2 + irinotecan arm",
          "data_type": "categorical_count_percentage",
          "percentage": 56.0,
          "raw_string": "44/56"
        },
        {
          "group_name": "All",
          "data_type": "categorical_count_percentage",
          "percentage": 56.0,
          "raw_string": "44/56"
        }
      ]
    }
  ]
}